Glucose metabolism in patients with essential hypertension.
about
A Targeted Metabolomics MRM-MS Study on Identifying Potential Hypertension Biomarkers in Human Plasma and Evaluating Acupuncture EffectsDistinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Metabolic syndrome in South Asians.Metabolomics, Lipidomics and Pharmacometabolomics of Human Hypertension.Prevalence of diabetes and unrecognized diabetes in hypertensive patients aged 40 to 79 years in southwest ChinaCentral obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIOperative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects.Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 studyDiagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitionsManagement of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry.Combined Treatment with Amlodipine and Atorvastatin Calcium Reduces Circulating Levels of Intercellular Adhesion Molecule-1 and Tumor Necrosis Factor-α in Hypertensive Patients with PrediabetesInsulin resistance in Nigerians with essential hypertensionPrevalence of diabetes mellitus in outpatients with essential hypertension in China: a cross-sectional study.Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease.A new antihypertensive drug ameliorate insulin resistance.Current status of glucose test prescription for hypertensive outpatients.Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents.The heme oxygenase system selectively suppresses the proinflammatory macrophage m1 phenotype and potentiates insulin signaling in spontaneously hypertensive rats.Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension.Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.Glucometabolic state of in-hospital patients with primary hypertension in sub-population of partial regions in China.Cardiovascular risk stratification and antihypertensive therapy according to guidelines in the outpatient setting.
P2860
Q28834202-B102AC7F-96EF-4289-A4DF-9C1674604C1CQ33821236-229CC82D-CF38-4E5F-8272-C86CD670E1A6Q35686352-CD953F96-3EFC-426A-B4F2-84AE467ED4D7Q36159065-12FAD84E-B866-415B-BA90-ACDC1B1A29CCQ36278562-30716E78-C8A5-40EB-BA58-3545939B7179Q36333227-E08D9214-C3F6-48A7-90C6-13F7D8BBC715Q36632433-58F5348F-01E3-4D44-8E7B-61F2C51411A3Q36665733-33C38ABE-C406-4FC1-A40B-FDBC4073D7FBQ36682368-BDED2F38-0C7F-4510-83C6-D7563E4667CEQ36812792-9D6ED07C-336C-4293-A0E4-89FC5EDBA2E8Q36942679-979FB2AC-6027-484A-81BE-7EAF8484000FQ37066747-713360E1-67F8-468C-805C-F5634ABB9BFAQ37201842-FF8C1951-308C-4C6A-927E-A8954A4E8DCFQ37299014-F8727827-A5DE-4108-BD10-64FC53BC040CQ37342431-7A609564-4A64-42BF-BD7D-B6A0FAB15B14Q37761303-3B607A33-33F5-43C1-8650-678658732CA4Q38679997-D7799C68-8B10-4161-826D-42F93CB627F1Q39028911-1054F426-2792-4AB1-A29C-3F1468DF8B26Q39620799-1D538C53-72E7-4C6D-8380-906CB4B5325AQ40238333-FBCD8551-6348-4235-823B-D5F11B2778D5Q46382698-F27EF271-AF74-4670-92D2-33F51F596818Q46388253-F297CD4F-4260-402C-82A7-2FA03275BC8CQ46409073-BD27852E-1DFA-469B-A3A6-EC22673A3F26Q46804714-DE023D0F-E43B-4BAF-A81A-71DF1B9C1D0BQ51527755-45C504B1-F17A-4E82-B625-B1EEBE80E024
P2860
Glucose metabolism in patients with essential hypertension.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Glucose metabolism in patients with essential hypertension.
@en
Glucose metabolism in patients with essential hypertension.
@nl
type
label
Glucose metabolism in patients with essential hypertension.
@en
Glucose metabolism in patients with essential hypertension.
@nl
prefLabel
Glucose metabolism in patients with essential hypertension.
@en
Glucose metabolism in patients with essential hypertension.
@nl
P2093
P1476
Glucose metabolism in patients with essential hypertension.
@en
P2093
AVANT Study Group Investigators
Jaime Fernández
Juan García-Puig
Manuel Luque
Rafael Ortega
P304
P356
10.1016/J.AMJMED.2005.09.010
P407
P577
2006-04-01T00:00:00Z